Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oropharyngeal Carcinoma (OPC)”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Not applicableStudy completedNCT02757222
What this trial is testing

Dose Escalation Versus Standard in Laryngopharyngeal Cancers

Who this might be right for
Malignant Neoplasm of Oropharynx Stage IIIMalignant Neoplasm of Larynx Stage IIIMalignant Neoplasm of Hypopharynx Stage III+5 more
Tata Medical Center 100
Not applicableLooking for participantsNCT07718620
What this trial is testing

HPV-associated Oropharyngeal Carcinoma (HPV-OPC)

Who this might be right for
Oropharyngeal Carcinoma (OPC)
Masaryk Memorial Cancer Institute 35
Not applicableLooking for participantsNCT06307015
What this trial is testing

De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Royal North Shore Hospital 25
Testing effectiveness (Phase 2)UnknownNCT04508829
What this trial is testing

Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy

Who this might be right for
Oropharyngeal Carcinoma
Fudan University 52
Testing effectiveness (Phase 2)UnknownNCT03669718
What this trial is testing

Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Who this might be right for
Squamous Cell Carcinoma of the OropharynxHPV16 Positive
ISA Pharmaceuticals 194
Not applicableStudy completedNCT02365844
What this trial is testing

Multispectral Imaging to Characterize Patterns of Vascular Supply Within Lymphoepithelial Mucosa in Oropharyngeal Cancer

Who this might be right for
Oropharyngeal CarcinomaOropharynx Cancer
Stanford University 81
Testing effectiveness (Phase 2)Looking for participantsNCT04901234
What this trial is testing

Adaptive RadioTherapy for OroPharynx Cancer

Who this might be right for
Oropharynx CancerRadiotherapy; ComplicationsRadiotherapy Side Effect+2 more
Centre hospitalier de l'Université de Montréal (CHUM) 120
Not applicableActive Not RecruitingNCT03644563
What this trial is testing

Men and Women Offering Understanding of Throat HPV

Who this might be right for
Oropharyngeal CancerHuman Papilloma Virus
Johns Hopkins University 1,500
Not applicableLooking for participantsNCT06305676
What this trial is testing

Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)

Who this might be right for
Oropharyngeal CancerHPV-Related Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 400
Large-scale testing (Phase 3)Active Not RecruitingNCT04116047
What this trial is testing

CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)

Who this might be right for
Oropharyngeal Cancer
University of Birmingham 785
Testing effectiveness (Phase 2)Looking for participantsNCT05307939
What this trial is testing

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

Who this might be right for
HPVOropharynx CancerHPV-Related Carcinoma+2 more
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT04398524
What this trial is testing

A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
ISA Pharmaceuticals 65
Testing effectiveness (Phase 2)Looking for participantsNCT07209189
What this trial is testing

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

Who this might be right for
Head and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+6 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 75
Not applicableUnknownNCT06097936
What this trial is testing

New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer

Who this might be right for
PREDICTIVE BIOMARKERSEvaluation of HPV-specific E5 Transcript Expression in a Cohort of Patients With HPV-associated OPCHPV 16 Positive Oropharyngeal Tumors (OPC)
Regina Elena Cancer Institute 20
Not applicableActive Not RecruitingNCT05814549
What this trial is testing

A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC)

Who this might be right for
Oropharyngeal CancerHPV-Related CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center 9
Large-scale testing (Phase 3)Not Yet RecruitingNCT07768189
What this trial is testing

Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oropharyngeal Carcinoma (OPC)
Corbus Pharmaceuticals Inc. 260
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07418034
What this trial is testing

A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CancerHead and Neck Squamous Cell Carcinoma+11 more
University of Maryland, Baltimore 132